WO2004052312A3 - Anti-infectives - Google Patents

Anti-infectives Download PDF

Info

Publication number
WO2004052312A3
WO2004052312A3 PCT/US2003/039982 US0339982W WO2004052312A3 WO 2004052312 A3 WO2004052312 A3 WO 2004052312A3 US 0339982 W US0339982 W US 0339982W WO 2004052312 A3 WO2004052312 A3 WO 2004052312A3
Authority
WO
WIPO (PCT)
Prior art keywords
infectives
disclosed
making
methods
same
Prior art date
Application number
PCT/US2003/039982
Other languages
French (fr)
Other versions
WO2004052312A2 (en
Inventor
Deping Chai
Kevin J Duffy
Duke M Fitch
Antony N Shaw
Rosanna Tedesco
Kenneth J Wiggall
Michael N Zimmerman
Original Assignee
Smithkline Beecham Corp
Deping Chai
Kevin J Duffy
Duke M Fitch
Antony N Shaw
Rosanna Tedesco
Kenneth J Wiggall
Michael N Zimmerman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp, Deping Chai, Kevin J Duffy, Duke M Fitch, Antony N Shaw, Rosanna Tedesco, Kenneth J Wiggall, Michael N Zimmerman filed Critical Smithkline Beecham Corp
Priority to AU2003300956A priority Critical patent/AU2003300956A1/en
Publication of WO2004052312A2 publication Critical patent/WO2004052312A2/en
Publication of WO2004052312A3 publication Critical patent/WO2004052312A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Compounds useful as HCV anti-infectives are disclosed. Also disclosed are methods of making and using the same.
PCT/US2003/039982 2002-12-11 2003-12-11 Anti-infectives WO2004052312A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003300956A AU2003300956A1 (en) 2002-12-11 2003-12-11 Anti-infectives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43241302P 2002-12-11 2002-12-11
US60/432,413 2002-12-11

Publications (2)

Publication Number Publication Date
WO2004052312A2 WO2004052312A2 (en) 2004-06-24
WO2004052312A3 true WO2004052312A3 (en) 2007-08-02

Family

ID=32507921

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/039982 WO2004052312A2 (en) 2002-12-11 2003-12-11 Anti-infectives

Country Status (2)

Country Link
AU (1) AU2003300956A1 (en)
WO (1) WO2004052312A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2327764T3 (en) 2004-08-23 2009-11-03 F. Hoffmann-La Roche Ag ANTIVIRICAL HETEROCICLIC COMPOUNDS.
ATE409179T1 (en) 2004-12-21 2008-10-15 Hoffmann La Roche TETRALIN AND INDANDE DERIVATIVES AND THEIR APPLICATIONS AS 5-HT ANTAGONISTS
MX2007013415A (en) 2005-05-04 2008-01-15 Hoffmann La Roche Heterocyclic antiviral compounds.
JP4969444B2 (en) * 2005-06-14 2012-07-04 ディナベック株式会社 Antibody production method
NZ567285A (en) 2005-11-03 2010-06-25 Hoffmann La Roche Arylsulfonylchromans as 5-HT6 inhibitors indolylmaleimide derivatives as protein kinase inhibitors
EA018935B1 (en) 2006-10-10 2013-11-29 Медивир Аб Hcv nucleoside inhibitor
CA2752443A1 (en) 2009-03-06 2010-09-10 F. Hoffmann-La Roche Ag Heterocyclic antiviral compounds
JP2012524752A (en) 2009-04-25 2012-10-18 エフ．ホフマン−ラ ロシュ アーゲー Heterocyclic antiviral compounds
CN102803212A (en) 2009-06-24 2012-11-28 弗·哈夫曼-拉罗切有限公司 Heterocyclic Antiviral Compound
BR112012005616A2 (en) 2009-09-21 2016-06-21 Hoffmann La Roche heterocyclic antiviral compounds
CN102713630A (en) 2009-11-14 2012-10-03 弗·哈夫曼-拉罗切有限公司 Biomarkers for predicting rapid response to HCV treatment
BR112012012085A2 (en) 2009-11-21 2016-05-17 Hoffmann La Roche heterocyclic antiviral compounds
RU2012127201A (en) 2009-12-02 2014-01-20 Ф.Хоффманн-Ля Рош Аг BIOMARKERS FOR FORECASTING A SUSTAINABLE RESPONSE TO THE TREATMENT OF HEPATITIS C VIRUS
RU2534613C2 (en) 2013-03-22 2014-11-27 Александр Васильевич Иващенко Alkyl2-{[(2r,3s,5r)-5-(4-amino-2-oxo-2h-pyrimidine-1-yl)- -hydroxy- tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-proptonates, nucleoside inhibitors of rna-polymerase hcv ns5b, methods for producing and using them
FR3053968A1 (en) * 2016-07-13 2018-01-19 Biomerieux REAGENTS FOR THE REVERSIBLE PROTECTION OF BIOLOGICAL MOLECULES

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6919331B2 (en) * 2001-12-10 2005-07-19 Bristol-Myers Squibb Company Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6919331B2 (en) * 2001-12-10 2005-07-19 Bristol-Myers Squibb Company Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents

Also Published As

Publication number Publication date
AU2003300956A1 (en) 2004-06-30
AU2003300956A8 (en) 2004-06-30
WO2004052312A2 (en) 2004-06-24

Similar Documents

Publication Publication Date Title
WO2003059356A3 (en) Novel anti-infectives
MXPA03011329A (en) Novel anti-infectives.
AU2003222544A1 (en) Homing process
AU2003262747A1 (en) Compounds, compositions, and methods
AU2003236527A1 (en) Compounds, compositions, and methods
AU2003265242A1 (en) Compounds, compositions, and methods
AU2003222408A1 (en) Garment and method for producing the same
AU2003270015A1 (en) Compounds, compositions, and methods
AU2003238930A1 (en) Enzymes
AU2003226094A1 (en) Compounds and methods
AU2003299612A1 (en) Compounds, compositions and methods
AU2003220558A1 (en) Amide compounds and methods of using the same
WO2003037262A3 (en) Novel anit-infectives
WO2004052312A3 (en) Anti-infectives
WO2004058150A3 (en) Anti-infectives
WO2004052313A3 (en) Anti-infectives
AU2003228826A1 (en) Polypropylene composoitions methods of making the same
AU2003206512A1 (en) Decorated panel and method of making the same
AU2003290507A1 (en) Compounds, compositions and methods
AU2003277079A1 (en) Compounds, compositions, and methods
AU2003297612A1 (en) 2-substituted-3-propenamide derivatives and methods of using the same
WO2004047751A3 (en) Calcilytic compounds
AU2003267169A1 (en) Compounds, compositions and methods
AU2003300031A1 (en) Compounds, compositions, and methods
EP1517879A4 (en) Aminoalkylphenols, methods of using and making the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AU BA BB BR BZ CA CN CO CR CU DM DZ EC EG GD GE HR ID IL IN IS JP KP KR LC LK LR LT LV MA MG MK MN MX NO NZ OM PH PL RO SC SG TN TT UA US UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP